Physician profile
Cedric D Shorter
NPI 1194936096
$1,136.55
in general payments reported to CMS, 2019-2025
14 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $102 · 2021: $53.65 · 2022: $146 · 2023: $268 · 2024: $127 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $261.48 | 2019-2023 | Teligen, Symphony, Sentio |
| Medtronic, INC. | $241.61 | 2022-2025 | Powerease Instruments, Infinity Occipitocervical Upper Thoracic System, Inceptiv |
| Synaptive Medical INC. | $161.20 | 2019 | |
| Heron Therapeutics, INC. | $97.41 | 2025 | Aponvie |
| Stryker Corporation | $76.03 | 2024 | Mild Device Kit |
| Integra Lifesciences Corporation | $52.14 | 2019-2022 | |
| Globus Medical, INC. | $51.20 | 2019 | |
| Orthofix Medical, INC. | $35.94 | 2020-2023 | Truelok System, Trinity Elite |
| Nevro Corp. | $32.46 | 2021-2023 | Senza |
| Medtronic USA, INC. | $31.97 | 2020 | |
| Gt Medical Technologies, INC | $31.89 | 2025 | Gammatile |
| Kerecis Limited | $25.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Novocure INC. | $21.09 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.96 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cedric Shorter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.